Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

46.54USD
22 Feb 2019
Change (% chg)

$2.38 (+5.39%)
Prev Close
$44.16
Open
$44.69
Day's High
$46.64
Day's Low
$44.19
Volume
121,818
Avg. Vol
253,099
52-wk High
$82.68
52-wk Low
$33.06

Select another date:

Mon, Aug 27 2018

Esperion's combo therapy lowers cholesterol level by 35 percent, shares surge

Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic acid, taken along with Merck's Zetia lowered cholesterol level by 35 percent in a late-stage study, sending the company's shares up as much as 11 percent.

UPDATE 1- Esperion's combo therapy lowers cholesterol level by 35 pct, shares surge

Aug 27 Esperion Therapeutics Inc said on Monday a combination of its drug, bempedoic acid, taken along with Merck's Zetia lowered cholesterol level by 35 percent in a late-stage study, sending the company's shares up as much as 11 percent.

Select another date: